1939.3000 3.70 (0.19%)
NSE Oct 10, 2025 15:31 PM
Volume: 867.4K
 

1939.30
0.19%
Reliance Securities
ff Management expects slowdown in Venezuela as it is hard to obtain the requisite import license. Potential threat of significant devaluation in Venezuela puts US$2030mn of company's exposure there at risk. As per our estimates, Venezuela contributed ~6% of FY15 profits. Factoring in the devaluation in FY17E, we...
Glenmark Pharmaceuticals Ltd. has gained 40.91% in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended